XML 124 R105.htm IDEA: XBRL DOCUMENT v3.22.1
Share-Based Compensation (Tables)
3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Schedule of Stock option activity

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

Weighted

    

Weighted-

    

​

​

​

​

​

​

Average Exercise

​

Averages Life

​

Aggregate

​

    

Stock Options

    

Price

    

(Years)

    

Intrinsic Value

Balance as of December 31, 2021

​

5,031,310

​

$

6.85

​

9.2 years

​

$

120,491

Retroactive application of recapitalization

​

10,681,124

​

$

(4.66)

​

  

​

  

​

Balance as of December 31, 2021

 

15,712,434

​

$

2.19

 

  

 

​

  

Exercised

 

(194,977)

​

$

0.54

 

  

 

​

  

Cancelled/Forfeited/Expired

 

(556,497)

​

$

0.63

 

  

 

​

  

Balance as of March 31, 2022

 

14,960,960

​

$

2.27

 

8.7 years

​

$

472,858

Vested and exercisable as of March 31, 2022

 

4,549,923

​

$

0.80

 

8.0 years

​

$

150,512

 
Schedule of stock options valuation assumptions

​

​

​

​

Fair value of common stock

$

6.11

 

Expected term (years)

 

5.3

​

Expected volatility

 

40.0

%

Risk-free interest rate

 

0.7

%

Expected dividend yield

 

0.0

%

​

​

    

2021

    

2020

​

Fair value of common stock

​

$8.80 – $21.29

​

$3.41 – $6.59

​

Expected term (years)

​

5.1 – 7.0

​

5.0 – 6.2

​

Expected volatility

​

40.0% – 41.4%

​

37.0% – 41.7%

​

Risk-free interest rate

​

0.7% –1.3%

​

0.3% – 0.8%

​

Expected dividend yield

​

0.0%

​

0.0%

​

Schedule of unvested stock options activity  

​

​

​

​

​

​

​

​

    

Number of 

    

Carrying 

​

​

Shares

​

Value

Unvested as of December 31, 2019

 

86,032

​

$

115

Exercised

 

1,375

​

$

2

Repurchased

 

(42,073)

​

$

(49)

Vested

 

(24,394)

​

$

(32)

Unvested as of December 31, 2020

 

20,940

​

$

36

Exercised

 

463,816

​

$

917

Repurchased

 

(13,876)

​

$

(23)

Vested

 

(88,841)

​

$

(145)

Unvested as of December 31, 2021

 

382,039

​

$

785

Restricted Stock [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Schedule of unvested stock options activity  

​

​

​

​

​

​

​

​

​

​

​

Weighted-

​

​

​

​

average

​

​

Number of 

​

Grant Date

​

    

Shares

    

Fair Value

Unvested balance as of December 31, 2019.

 

1,940,130

​

$

1.21

Granted

 

—

​

$

—

Vested

 

(541,704)

​

$

1.69

Cancelled/Forfeited

 

—

​

$

—

Unvested balance as of December 31, 2020.

 

1,398,426

​

$

1.02

Granted

 

—

​

$

—

Vested

 

(500,000)

​

$

1.78

Cancelled/Forfeited

 

—

​

$

—

Unvested balance as of December 31, 2021

 

898,426

​

$

0.60

Share-based Payment Arrangement, Option    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Schedule of Stock option activity  

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted-

​

Aggregate

​

​

​

​

Weighted-average

​

averages

​

Intrinsic

​

    

Stock Options

    

Exercise Price

    

Life (Years)

    

Value

Balance as of December 31, 2019

 

1,081,579

​

$

2.31

 

8.9

​

$

2,817

Granted

 

3,251,443

​

$

2.60

 

​

​

 

  

Exercised

 

(307,778)

​

$

1.56

​

​

​

​

​

Cancelled/Forfeited/Expired

 

(816,181)

​

$

2.03

​

​

​

 

  

Balance as of December 31, 2020

 

3,209,063

​

$

1.57

​

9.1

​

$

16,094

Granted

 

3,457,020

​

$

9.37

​

​

​

 

  

Exercised

 

(1,247,236)

​

$

1.68

​

​

​

​

​

Cancelled/Forfeited/Expired

 

(387,537)

​

$

2.00

​

​

​

 

  

Balance as of December 31, 2021

 

5,031,310

​

$

6.85

​

9.2

​

$

120,491

Vested and exercisable as of December 31, 2021

 

1,284,624

​

$

2.33

​

8.3

​

$

36,579

Schedule of stock options valuation assumptions  

​

​

​

​

​

​

Fair value of common stock

​

$

19.07

 

Expected term (years)

​

 

5.3

​

Expected volatility

​

 

40.0

%

Risk-free interest rate.

​

 

0.7

%

Expected dividend yield

​

 

0.0

%